chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician (D.O.) concerning a 34 year old female who on 08-MAR-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (lot# 669533/1383Z, dose and route not reported). The patient was supposed to receive VARIVAX (Merck). No adverse events were reported. The patient did not seek medical attention. Follow up information has been received from the physician concerning a female patient who on 08-MAR-2011 at 8:30 was subcutaneously vaccinated with a dose of ZOSTAVAX (Merck) (lot# 669533/1383Z). Additional information has been requested.
For 1 wk after - can't lift arm (left) - headaches - fever - aches (whole body) - nausea - mental sluggishness + fogginess [ A extra strength Tylenol + Aspirin only relieved slightly]
Information has been received from a physician concerning a 25 month old male who on 27-JUL-2007 was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck) (Lot# 652555/1023R). Concomitant therapy included a second dose of hepatitis A vaccine (inactive) (MSD) (Lot# 656993/0001U). On 29-JUL-2007, the patient developed a 105.2 degree fever after vaccination. On 30-JUL-2007, the patient also developed two blisters on his arm at 7:30 morning and evening. On 31-JUL-2007 the patient's temperature was from 101.4 to 102.9 degrees. Unspecified medical attention was sought. Subsequently, the patient was noted to be recovering. There was no product quality complaint. Additional information has been requested.
Chills; muscle aches; fever; Not able to work; Extreme tiredness; This is a spontaneous report from a contactable consumer (patient). A 53-years-old male patient received the first dose of BNT162B2 (Lot number: eH9899), via an unspecified route of administration, in arm left, on 18Dec2020 17:00 at single dose for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered was hospital. Medical history included heart valve replacement. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, patient was not tested for COVID-19. No allergies to medications, food, or other products. No other vaccines were received within 4 weeks prior to the COVID vaccine. The other medication that the patient received within 2 weeks of vaccination was atenolol. The patient experienced chills, muscle aches, fever, not able to work and extreme tiredness on 19Dec2020 06:00 AM. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovered in Dec2020.
14 days after receiving H1N1 vaccine, the patient's hairdresser noticed some bald spots on the back of the head.  These progressed to losing all hair on head.  The primary doctor diagnosed alopecia areata.  A dermatologist concurred with the diagnosis and prescribed topical glucocorticoids.  The hair is now slowly growing back.
This case meets criteria for vaccine breakthrough review.  Known household exposure. SxS include fever, weakness, diarrhea.
Information has been received from a health professional concerning a female with a history of morbid obesity who on 05-SEP-2007 was IM vaccinated with her first dose of Gardasil (lot number unspecified) in the left deltoid. On 26-DEC-2007 the patient received her second dose, previously reported as her first dose, of Gardasil (lot number unspecified) intramuscularly in the left hip. At an unspecified time, the patient returned to the office for the third injection, there was a palpable lump at the left hip injection site. The patient told the physician assistant that the lump was improved and had been much larger. The patient told the physician assistant that there had been an injection site rash at the left hip for an  unspecified period of time. On 26-Dec-2007 the patient experienced incorrect site, injection site rash and palpable lump at injection site. Additional information has been requested. Additional information received from the physician indicated the patient experienced the adverse events for approximately 1 month. The patient recovered from injection site rash and palpable lump on 24-Jan-2008.
Information has been received from a 67 year old female consumer with a sulfonamide allergy, who on 28-AUG-2008 was vaccinated with a first dose of PNEUMOVAX. Concomitant therapy included ARMOUR THYROID TABLETS. On 28-AUG-2008, after the vaccination, the patient experienced excruciating pain at the injection site, with redness and swelling from the shoulder to the elbow. She also developed bruising on all of her fingers. She sought unspecified medical attention. No diagnostic laboratory studies were performed. She is getting better, but the site is still tender to touch. No product quality complaint was involved. Follow up information was received from a health professional who reported that in the afternoon of 28-AUG-2008 the patient vaccinated with a dose of PNEUMOVAX (lot # 659199/1541U) in her right deltoid. On 28-AUG-2008 the patient experienced injection site swollen and tender which was down to elbow in the right side. The patient was treated with elevation ice, TYLENOL. The patient was offered an appointment but declined. Subsequently, the patient recovered. Follow up information was received from the patient was a female with an allergy to BACTRIM, ZITHROMAX, AVELOX and LEVAQUIN who at 3 PM of 28-AUG-2008 was vaccinated with a dose of PNEUMOVAX. No illness was reported at the time of vaccination. At 7:22 PM of 28-AUG-2008 the patient experienced right arm swollen and tender. No laboratory or diagnostic test was performed. At the time of this report, the patient recovered. Additional information is not expected.
1 hour after immunizations: Fever (+): 101 degrees at 9:30AM, 103 degrees at 14:30, 105.6 degrees at 16:30. Vomiting x1, hands and feet purple, nodular rash on trunk, posterior-anterior.
Second dose of Pfizer was given a week earlier that recommended.  patient also received her flu vaccine.  She was brought in by her mom.  Mom has been called to advised to monitor patient and that an incident report with be filed.
Info has been received from a physician concerning a 10 year old white male who on 6/19/95, was vaccinated with a dose of varicella virus vaccine live. The physician reported that on 2/1/05, the developed breakthrough chickenpox during a local outbreak in his school. Subsequently, the pt recovered from the breakthrough chickenpox. No further info is available.
About 5 days after the second shot, I had a very large, red, raised rash, the size of my hand extending from my shoulder to my elbow on my left arm. It was very hot and painful. After a couple weeks it led to me having left arm weakness. I finally saw my doctor, who sent me to physical therapy. I went to physical therapy for 8 weeks and it finally got better. I think the nurse who gave me my vaccine injected too high on my arm and that may have caused part of the problem. My arm is completely back to normal now. I had no problems with the booster.
Large, itchy, at times painful welt and rash around injection site. Rash is about 3in diameter.
On 03/20/09 I received ZOSTAVAX -Merck # 971651. No immediate side-effects except mild erythema at site. On 5/28/09 I had attack of severe vertigo: no unusual--I've had occasional vertigo for years, thoroughly investigated, considered benign, usually following stress or sleep-deprivation. This time, however, feelings of malaise, instability, confusion persisted and on 6/08/09 I broke out in a herpes-like rash---small crops of papules, pruritic, not painful, not following dermatomes, more like attenuated chicken pox. Initially on chest and abdomen, but small papules continued to break out for several weeks, involving extremities as well. Malaise, instability, confusion gradually resolved and I have just returned from vacation abroad, involving high level of physical activity, highly enjoyable. Was this an adverse effect of vaccine? You judge: I thought it worthwhile reporting because of bizarre reactions to illness/drugs/vaccines in people over 80.
Swelling and pain of both wrists. Right worst than left. Resolved four days later.
This spontaneous report was received from a pharmacist refers to a 59 year old female patient with Sjogren's syndrome and codeine allergy. The patient's medical history included previous shingles outbreak for the past few years and was treated with valacyclovir. It was not diagnosed as Shingles until June 2012. Patient also had a back surgery in July 2012 before the shingles outbreak. Pharmacist stated that the patient got a shingles outbreak every 2-3 months. The therapy reason for use was the patient tired of getting recurrent shingles every couple of months and wanted to lessen the frequency or duration of shingles. So on 21-MAR-2013, the patient was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (lot # H018798, expiry: 15-JAN-2014). Concomitant therapies included PLAQUENIL for Sjogren's syndrome but was told by her rheumatologist, to get the vaccination. On 01-APR-2013, the patient experienced an outbreak of shingles. It was currently limited to her "backside" and was red and itching. The pharmacist mentioned that the patient did take an unspecified antiviral medication on the 10th day after vaccination with ZOSTAVAX. No treatment was given for the event. No laboratory diagnostics studies were performed. Patient sought medical attention (called the pharmacy). The patient's present status was not recovered. The relatedness of the event with ZOSTAVAX was unknown. Additional information has been requested.
Felt lightheaded immediately after injection, but that sensation had disappeared before the 15 minute waiting period expired.  Began to experience body aches and sore arm approximately 12 hours after vaccine. Body aches lessened the following day, but I continued to experience strong fatigue and mild headache for two days following vaccination. By the third day all symptoms were gone, other than a mild ache at injection site.
This spontaneous case was retrieved on 18-Oct-2021 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 1715789-1), reported by other healthcare professional and concerned a 73-year-old, male patient. The patient's relevant medical history was not reported. The patient had no known allergies. The patient's concomitant medication included Atorvastatin (atorvastatin calcium), Losartan (losartan potassium), trazodone, Pantoprazole (Pantoprazole sodium sesquihydrate) and gabapentin, all used for an unreported indication. On 14-Sep-2021, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; route of administration: intramuscular (IM), anatomical location: right arm (RA), dose: 'one' as reported and indication: not reported). The batch number reported was 312828. On the same day, after receiving Fluad Quadrivalent, the patient experienced hives all over his arms and trunk. On 18-Sep-2021, the patient came to healthcare professional (HCP) who recommended that he take some Benadryl (diphenhydramine hydrochloride) and to let his doctor know about this reaction. The HCP documented the allergy in their system as well. The outcome of the events was unknown. The reporter did not provide a causality assessment. This case is assessed as non-serious. Company comment: The events of 'hives' and 'allergy' were assessed as related to Fluad Quadrivalent.; Sender's Comments: The events of 'hives' and 'allergy' were assessed as related to Fluad Quadrivalent.
pt devel urticaria over entire body following vax;urticaria was treated w/ 1.6ml DPH q 4hr & has resolved;
Hospital called to say client was 7 weeks pregnant now and when she received MMR vaccine on 11-3-14 she was 4 weeks pregnant and did not know this.
In PM of 24JAN96 t103-104 from 25th through 27th ran temp 3x daily;temp ranging from 105-105.7 using thermoscan-temp dec to 100 w/use of APAP;broke out in fine rash-torso & legs on 26JAN lasting 1 1/2 days;mom contacted MD & ER on 25JAN
Moderna COVID-19 Vaccine EUA Bruising and what appeared to be some kind of rash at injection site, some swelling, though no itching.  Some yellowing appeared just under the skin which seemed almost like the vaccine material itself. Approximately one week later, swelling began reducing, but began experiencing some vertigo.
The patient received Tdap immunization for puncture wound of the thigh at this clinic on July 9.  She had an immediate reaction consisting of numbness and pain from the armpit down to the middle of the forearm.  She told the nurses and she was observed for at least a half an hour.  The pain gradually subsided.  By the next day, she had minor pain and discomfort.  Since then, she has had persistent minor pain and discomfort with a hard time sleeping because of a sensation of her arm falling asleep.  She indicates the area of discomfort is from the axilla to the mid forearm, but she also has minor tingling of the fingers, which is occasional.  She notes that there might be increased tingling of the fingers depending on the position of her elbow and shoulder.  She is usually healthy.  Past medical history is negative (Gravida, Para, seven years ago).  The patient takes no medications and has environmental allergies.  Her daughter had a reaction to her MMR, again given at this clinic, a couple of years ago.  She looks well.  She has full range of motion of the neck, which does not increase her discomfort.  There is full range of motion of the shoulder, which produces some discomfort as she lowers the arm from full abduction.  Deep tendon reflexes are 2+ in biceps, triceps, supinator and knees.  Ankle reflexes are absent.  There is good strength of all muscle groups of both arms.  There is no sensory loss to vibration in the fingers.  On inspection of the shoulder, there is no obvious swelling, but there is a patchy fading ecchyinosis approximately 3 cm in diameter of the skin overlying the deltoid.  Sounds like an immunization reaction, which has persisted.  Notify manufacturers.  Request neurological opinion to be arranged for this week since she will be leaving for another city at the end of the week and has no regular physician in the other city.
Patient had itching on her right palm (hand) 2-3 after vaccination was given, no chest tightness, no dizziness, no altered breathing, no abdominal pain, no nausea or vomiting, no diaphoresis, no feeling of warmth or flushing, no altered vision, skin was normal to touch, not cool or clammy, no fever. Vital: BP: 135/78 P:76 O2: 96 R:22 At 10:35 We administered Benadryl 50mg and she drank 120cc of water. We talked to her about the side effect of the medication and monitored her. At 10:50am she said she felt better and wanted to leave, but we encouraged her to stay for 20 more minutes. Patient not driving, her husband drove. Encourage to drink more fluids and watch possible symptoms for over 48 hr, and seek medical help.
Rash on upper left arm, near injection site - two fingers in length and width, itchy, red, raised, disappeared after about 5 days.
Information reported by patient's wife 11/09/2005. Pt developed shortness of breath, wheezing and throat feeling sore, about 7 - 7:30 pm 11/08/05. They consulted pt's sister who is a doctor. I was advised to use Albuterol inhaler (from their child's rx) and also to take Benadryl 50 mgm and prednisone 20 mgm (colick they had on hand) and additional dose of Benadryl taken at 12. Felt better by 6 am.
Patient had appointment for Hepatitis B Vaccine. Nurse  administered Hepatitis B, Menactra and Tdap vaccines. Nurse notified patient's father of administration of Menactra and Tdap. Instructed that it is safe to receive at this time, but will need repeated at age 12. Will be considered extra doses.
injection site is hurting/aching; This is a spontaneous report from a contactable consumer (patient) via Pfizer- sponsored program. A female patient of an unspecified age received bnt162b2 (BNT162B2, Pfizer Covid 19 Vaccine), dose 1 via an unspecified route of administration on 08Apr2021 (Lot number was not reported) as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced injectionis hurting/aching, so put Arnicare Pain Relieving Gel. The event outcome was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This is a spontaneous report from a contactable pharmacist received via a Pfizer sales representative. A female patient of an unspecified age received the PREVNAR 13, on an unspecified date and then on another unspecified date; both via unspecified routes of administration at single doses for immunization. The patient's medical history and concomitant medications were not reported. On unspecified dates, the patient developed lumps at the injection sites. The clinical outcome of the event, lumps at the injection sites, was unknown. No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Mild headache the next day; Both armpits burning after approximately 20min after getting vaccine then went away about an hour later.; Vivid dreams; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0176) via an unspecified route of administration in the left arm on 30Apr2021 at 15:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included 4 titanium rods and 20 titanium screws implanted throughout the body. Concomitant medication included fluticasone propionate, salmeterol xinafoate (WIXELA INHUB); taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received clavulanate potassium; amoxicillin trihydrate (AMOXICLAV) taken for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021, the patient experienced both armpits burning after approximately 20 minutes after getting vaccine then went away about an hour later and also experienced vivid dreams. On 01May2021, the next day, the patient had mild headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event both armpits burning after approximately 20 minutes after getting vaccine then went away about an hour later was recovered on 30Apr2021. The clinical outcome of the events vivid dreams and mild headache were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a pharmacist via company representative, referring to a female patient in her thirties. The patient's pertinent medical history, concomitant therapies and drug/allergies reactions were not reported. Concurrent conditions included diabetes mellitus. On an unknown date, the patient in her thirties was vaccinated with a dose of ZOSTAVAX vial 19400 PFU (dose, route, lot # and expiration date were not reported) for prophylaxis. No adverse effects were reported. No product quality complaint (PQC) was involved in this report. Additional information has been requested.
Sent to Emergency room by telephone advice for short of breath, dizzy, and weak, muscle pains. Received intravenous fluids for orthostatic hypotension.
The patient presents with difficulty breathing.  Patient presents to emergency department cough as well shortness of breath or 1 week.  Patient describes fevers.  Patient with chest pain as well as vomiting but no diarrhea.  Patient states the vomiting has resolved.  Patient's symptoms have been constant since onset.  Patient has been on her normal O2 at home for her COPD.  Patient with recent admission for metabolic encephalopathy discharged on August 26.  Patient was negative for COVID at that time.  Patient had a COVID-19 vaccination in April of this year..
Had a high heart rate at rest. While sitting, not moving, I recorded 160 BPM and it would go as high as 178 BPM. Periodically sweating, dizziness and sick to my stomach. This lasted until 0830 the next day. I had no other issues. For most of this period my heart rate was around 120-140. If I just stood up, it would go right up to 160-170. This lasted approximately 19 hours...
swelling; had the pain in my right thigh; trouble sitting; trouble walking; it's feverish it's warm to touch; thigh is warm to the touch; This is a spontaneous report from a contactable consumer or other non-health care professional (patient).   A 57-year-old female patient received bnt162b2 PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: Patient not sure about lot number "It looks like EL3302 or is EL3502") via an unspecified route of administration in left arm on 19Apr2021 (at the age of 57-year-old) as dose 1, single for covid-19 immunization. Patient's medical history included migraine for which patient take migraine medication and high blood pressure from an unknown date and unknown if ongoing. Concomitant medications included losartan (LOSARTAN) for high blood pressure and bisoprolol (BISOPROLOL) taken for high blood pressure (Patient take high blood pressure medication, Losartan, Bisoprolol is 8 ctz, Losartan 100 mg. Bisoprolol is 10-6-25). On 21Apr2021 (2 days after vaccine) patient experienced swelling and had the pain in the right thigh. It was trouble sitting and trouble walking. and it was feverish it was warm to touch, patient's thigh was warm to the touch. Patient states they gave med for pain to get along with steroid (unspecified). Patient still experiencing and on medication from the doctor Methylprednisolone with dose 4 mg. Frequency of Methylprednisolone: 21 tablets, a different dose each day first day 6 dose 6 tablet, The second day 5 tablet, 3rd day 4 tablet, 4th day 3 tablet, 5th day 2 tablet. last day 1 tablet. It's a steroid. it's a steroid pack. The patient underwent lab tests and procedures which included blood test which resulted as clear, blood was fine on 21Apr2021. Patient received treatment for pain in right thigh. Outcome of events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.